ES2929981T3 - Dispersiones sólidas en polvo que comprenden quercetina, procedimiento para su preparación y formulaciones de las mismas - Google Patents

Dispersiones sólidas en polvo que comprenden quercetina, procedimiento para su preparación y formulaciones de las mismas Download PDF

Info

Publication number
ES2929981T3
ES2929981T3 ES18743743T ES18743743T ES2929981T3 ES 2929981 T3 ES2929981 T3 ES 2929981T3 ES 18743743 T ES18743743 T ES 18743743T ES 18743743 T ES18743743 T ES 18743743T ES 2929981 T3 ES2929981 T3 ES 2929981T3
Authority
ES
Spain
Prior art keywords
quercetin
process according
phospholipids
solution
carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES18743743T
Other languages
English (en)
Spanish (es)
Inventor
Massimo Ronchi
Elisabetta Frattini
Antonella Riva
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Indena SpA
Original Assignee
Indena SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena SpA filed Critical Indena SpA
Application granted granted Critical
Publication of ES2929981T3 publication Critical patent/ES2929981T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A61K8/022—Powders; Compacted Powders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Botany (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
ES18743743T 2017-07-17 2018-07-16 Dispersiones sólidas en polvo que comprenden quercetina, procedimiento para su preparación y formulaciones de las mismas Active ES2929981T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17181634 2017-07-17
PCT/EP2018/069284 WO2019016146A1 (en) 2017-07-17 2018-07-16 SOLID POWDER DISPERSIONS COMPRISING QUERCETIN, PROCESS FOR PREPARING SAME AND FORMULAS THEREOF

Publications (1)

Publication Number Publication Date
ES2929981T3 true ES2929981T3 (es) 2022-12-05

Family

ID=59381081

Family Applications (1)

Application Number Title Priority Date Filing Date
ES18743743T Active ES2929981T3 (es) 2017-07-17 2018-07-16 Dispersiones sólidas en polvo que comprenden quercetina, procedimiento para su preparación y formulaciones de las mismas

Country Status (17)

Country Link
US (1) US11331298B2 (cg-RX-API-DMAC7.html)
EP (1) EP3654938B1 (cg-RX-API-DMAC7.html)
JP (1) JP7284743B2 (cg-RX-API-DMAC7.html)
KR (1) KR20200030076A (cg-RX-API-DMAC7.html)
CN (1) CN110944624A (cg-RX-API-DMAC7.html)
AU (1) AU2018304534B2 (cg-RX-API-DMAC7.html)
CA (1) CA3069055A1 (cg-RX-API-DMAC7.html)
DK (1) DK3654938T3 (cg-RX-API-DMAC7.html)
ES (1) ES2929981T3 (cg-RX-API-DMAC7.html)
FI (1) FI3654938T3 (cg-RX-API-DMAC7.html)
HU (1) HUE060387T2 (cg-RX-API-DMAC7.html)
IL (1) IL271852B2 (cg-RX-API-DMAC7.html)
PL (1) PL3654938T3 (cg-RX-API-DMAC7.html)
PT (1) PT3654938T (cg-RX-API-DMAC7.html)
SG (1) SG11202000141WA (cg-RX-API-DMAC7.html)
SI (1) SI3654938T1 (cg-RX-API-DMAC7.html)
WO (1) WO2019016146A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210393579A1 (en) * 2020-06-23 2021-12-23 Zestt Wellness Limited Anthocyanin and Quercetin Based Formulations for Improved Respiratory Health
JP7123434B1 (ja) 2021-03-17 2022-08-23 株式会社アイビー化粧品 破骨細胞分化抑制剤
CN113712988A (zh) * 2021-08-17 2021-11-30 塔里木大学 一种槲皮素-替米考星聚合物纳米微粒、其制备方法及应用
IT202200002108A1 (it) 2022-02-07 2023-08-07 Indena Spa Composizioni a base di quercetina per il trattamento e la prevenzione di affezioni oculari
KR102653457B1 (ko) * 2023-12-20 2024-04-02 서울대학교산학협력단 장 점막 부착성이 향상된 쿼세틴 함유 분말 제제의 제조방법 및 이에 따라 제조된 쿼세틴 함유 분말 제제
KR20260108310A (ko) * 2024-12-30 2026-07-08 대상웰라이프 주식회사 구강 건강 개선용 조성물의 제조 방법 및 이로부터 제조된 구강 건강 개선용 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100370968C (zh) * 2005-12-06 2008-02-27 四川大学 槲皮素长效脂质体粉针剂及其制备方法
CN100367953C (zh) * 2006-03-06 2008-02-13 山东大学 槲皮素固体脂质纳米粒制剂及其制备方法
CN101904821A (zh) * 2009-06-02 2010-12-08 姜玲敏 槲皮素纳米冻干粉及其制备方法
CN102058536A (zh) 2011-01-14 2011-05-18 四川大学 槲皮素羟丙基β-环糊精包和物脂质体及其制备方法和用途

Also Published As

Publication number Publication date
EP3654938B1 (en) 2022-08-31
SG11202000141WA (en) 2020-02-27
IL271852A (en) 2020-02-27
HUE060387T2 (hu) 2023-02-28
IL271852B1 (en) 2024-03-01
AU2018304534B2 (en) 2024-07-11
CN110944624A (zh) 2020-03-31
JP7284743B2 (ja) 2023-05-31
IL271852B2 (en) 2024-07-01
JP2020527549A (ja) 2020-09-10
RU2020106924A3 (cg-RX-API-DMAC7.html) 2021-11-17
AU2018304534A1 (en) 2020-02-06
US11331298B2 (en) 2022-05-17
RU2020106924A (ru) 2021-08-17
SI3654938T1 (sl) 2022-11-30
KR20200030076A (ko) 2020-03-19
PT3654938T (pt) 2022-11-03
FI3654938T3 (fi) 2022-12-15
BR112020000841A2 (pt) 2020-07-21
CA3069055A1 (en) 2019-01-24
WO2019016146A1 (en) 2019-01-24
US20200206186A1 (en) 2020-07-02
PL3654938T3 (pl) 2022-12-27
EP3654938A1 (en) 2020-05-27
DK3654938T3 (da) 2022-10-03

Similar Documents

Publication Publication Date Title
JP7284743B2 (ja) ケルセチンを含む粉末固体分散体、その調製方法およびその製剤
JP5343002B2 (ja) 生理活性物質含有組成物
US20090004170A1 (en) Composition comprising coenzyme q10
JPS63277691A (ja) サポニンとりん脂質との複合体及びそれらを含有する薬学的及び化粧用の組成物
Huang et al. Surfactant-free solid dispersion of BCS class IV drug in an amorphous chitosan oligosaccharide matrix for concomitant dissolution in vitro-permeability increase
JPWO2008053920A1 (ja) 生理活性物質含有粒子状組成物およびその製造方法
WO2011088688A1 (zh) 以氨基酸为稳定剂的聚合物胶束载药系统
WO2009115023A1 (zh) 花色苷磷脂复合物及其制备方法
Tian et al. Fabrication of nanosuspensions to improve the oral bioavailability of total flavones from Hippophae rhamnoides L. and their comparison with an inclusion complex
AU2005290583A1 (en) Fine particles-containing composition and manufacturing method therefor
Wong et al. A trade-off between solubility enhancement and physical stability upon simultaneous amorphization and nanonization of curcumin in comparison to amorphization alone
WO2021013262A1 (zh) 一种阿可拉定的纳米胶束制剂及其制备方法和用途
US11951169B2 (en) Pharmaceutical preparation with curcuminoids nanoparticles and a method for producing the same
RU2772020C2 (ru) Порошкообразные твердые дисперсии, включающие кверцетин, способ их получения и их композиции
JP6348024B2 (ja) 水分散性の良いシリマリン含有組成物
BR112020000841B1 (pt) Dispersões sólidas de pó compreendendo quercetina, processo para seu preparo e suas formulações
HK40023880A (en) Powder solid dispersions comprising quercetin, process for their preparation and formulations thereof
Volkova et al. Modified release and permeation of umifenovir with SBE-β-cyclodextrin and polymer: impact of biorelevant gastrointestinal fluids
KR102556990B1 (ko) 저항성 전분으로 코팅된 딱지꽃 추출물 봉입 고체 지질 나노입자 및 그 제조방법
ES2787229T3 (es) Composición que contiene coenzima Q10
DE102012221900A1 (de) Feste Lösungen von Coffein
CN114129518B (zh) 一种氟可拉定的纳米胶束制剂及其制备方法和用途
Liu Preparation of surfactant incorporated third-generation solid dispersion formulations for curcumin to enhance drug solubility and oral bioavailability
Sharma et al. Pharmacosomes as Unique and Potential Drug Delivery System
WO2026102214A1 (en) Pharmaceutical compositions comprising edaravone